logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Shinsuke Sasada

Research Institute for Radiation Biology and Medicine
H指数:23
被引数:1,465

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Distinct risk profiles of heart failure and non-heart failure major adverse cardiovascular events among patients with early breast cancer: a competing-risk analysis

早期乳腺癌患者中心力衰竭与非心力衰竭主要心血管不良事件的不同风险特征：一项竞争风险分析

International Journal of Clinical Oncology
IF2.8
2026-09-150
OAAI
Hideo Shigematsu; Atsuyoshi Norishige; Kazuaki Tanabe; Hiroyuki Sawatari; Yukiko Nakano; Ai Amioka; Daiki Okamoto; Sakiko Hino; Haruka Ikejiri; Shinsuke Sasada; Morihito Okada
Lactobacillus reuteri lozenges and chemotherapy-induced oral mucositis in breast cancer outpatients: an exploratory randomized controlled trial

罗伊氏乳杆菌含片与化疗诱导的乳腺癌门诊患者口腔黏膜炎：一项探索性随机对照试验

Scientific Reports
IF3.9
2026-07-110
OA
Hiromi Nishi; Susumu Horikoshi; Shinsuke Sasada; Yuki Kuwabara; Kouji Ohta; Hideo Shigeishi; Yukio Yoshioka; Masaru Konishi; Marino Yoshida; Tetsuya Yoshimoto; Kanako Yano; Miyuki Nakaoka; Hideo Shigematsu; Kotaro Tanimoto; Naoya Kakimoto; Hiroki Ohge; Hiroyuki Kawaguchi
Annual report of national clinical database-breast cancer registry in 2023: systemic therapy for small breast cancer

2023年国家临床数据库-乳腺癌登记年报：小乳腺癌的系统治疗

Breast Cancer
IF2.9
2026-06-120
OAAI
Shinsuke Sasada; Hiraku Kumamaru; Naoko Kinukawa; Takayuki Iwamoto; Masahiro Kawashima; Takaaki Konishi; Shigehira Saji; Naoko Sanuki; Kenta Tanakura; Masayuki Nagahashi; Minoru Miyashita; Masayuki Yoshida; Takayuki Kinoshita; Yasuaki Sagara; Naoki Niikura; Takanori Ishida; Naruto Taira
Breast reconstruction-related complications from postmastectomy radiation therapy in stage II–III breast cancer: sub-analysis of a multi-institutional observational study (Reborn-03)

乳腺癌根治术后放疗相关的乳房重建并发症：一项多中心观察性研究（Reborn-03）的亚组分析

Breast Cancer
IF2.9
2025-11-180
OAAI
Shinsuke Sasada; Wakako Tsuji; Noriyuki Watanabe; Ayaka Shimo; Natsue Uehiro; Takahiro Tsukioki; Naomi Nagura; Shoichi Tomita; Hiroko Nogi; Kei Yamaguchi; Kazuhiko Yamagami; Akiko Ogiya; Hiromi Suetsugu; Yuki Nakamura; Chikako Yamauchi; Hirohito Seki
Association between adjuvant chemotherapy and outcomes in resected locoregional recurrence of hormone receptor-positive HER2-negative breast cancer: a multi-institutional retrospective study

激素受体阳性HER2阴性乳腺癌局部区域复发切除术后辅助化疗与预后的关系：一项多中心回顾性研究

ESMO Open
IF8.3
2025-11-070
OAAI
Y. Ozaki; E. Tokuda; Y. Sagara; F. Hara; S. Sasada; M. Sawaki; C. Kanbayashi; T. Yamanaka; T. Onishi; Y. Fujiki; A. Suto; Y. Takahashi; E. Tokunaga; T. Aruga; R. Nakamura; T. Fujisawa; S. Saji; H. Iwata; T. Shien
Effectiveness of post-mastectomy radiation therapy after breast reconstruction for patients with high-risk breast cancer: A retrospective multicenter cohort study (Reborn Study-03)

乳腺癌高风险患者术后乳房重建后辅助乳腺切除术后放疗的有效性：一项回顾性多中心队列研究（Reborn Study-03）

European Journal of Surgical Oncology
IF2.9
2025-10-160
PRE
Wakako Tsuji; Shinsuke Sasada; Noriyuki Watanabe; Shoichi Tomita; Ayaka Shimo; Natsue Uehiro; Takahiro Tsukioki; Naomi Nagura; Hiroko Nogi; Kei Yamaguchi; Kazuhiko Yamagami; Akiko Ogiya; Hiromi Suetsugu; Yuki Nakamura; Hirotsugu Isaka; Tomohiro Shiraishi; Yutaka Nishida; Chikako Yamauchi; Hirohito Seki
Impact of radiation therapy on breast satisfaction and health-related quality of life after breast reconstruction: a multicenter cross-sectional controlled study (Reborn study-02)

放射治疗对乳房重建后乳房满意度及健康相关生活质量的影响：一项多中心横断面对照研究（Reborn研究-02）

Breast Cancer
IF2.9
2025-08-220
PRE
Hirohito Seki; Noriyuki Watanabe; Naomi Nagura; Akiko Ogiya; Ayaka Shimo; Natsue Uehiro; Wakako Tsuji; Shoichi Tomita; Takahiro Tsukioki; Hirotsugu Isaka; Tomohiro Shiraishi; Yutaka Nishida; Chikako Yamauchi; Shinsuke Sasada
Annual report of National Clinical Database-Breast Cancer Registry in 2021: characteristics categorized by body mass index and menopause status

2021年国家临床数据库—乳腺癌登记系统年度报告：按体重指数和绝经状态分类的特征

BREAST CANCER
IF2.9
2025-04-210
OA
Konishi, Takaaki; Kumamaru, Hiraku; Niikura, Naoki; Sagara, Yasuaki; Miyashita, Minoru; Iwamoto, Takayuki; Sanuki, Naoko; Tanakura, Kenta; Nagahashi, Masayuki; Yoshida, Masayuki; Kawashima, Masahiro; Kinoshita, Takayuki; Sasada, Shinsuke; Kinukawa, Naoko; Saji, Shigehira; Ishida, Takanori; Taira, Naruto
Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2-advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study)
BREAST CANCER
IF2.9
2025-04-010
OAAI
Nagai, Shigenori E.; Hattori, Masaya; Yoshinami, Tetsuhiro; Masuda, Hiroko; Okamura, Takuho; Watanabe, Kenichi; Nakayama, Takahiro; Tsuneizumi, Michiko; Takabatake, Daisuke; Harao, Michiko; Yoshino, Hiroshi; Mori, Natsuko; Yasojima, Hiroyuki; Oshiro, Chiya; Iwase, Madoka; Yamaguchi, Miki; Sangai, Takafumi; Sasada, Shinsuke; Ishida, Takanori; Futamura, Manabu; Muramatsu, Yasuaki; Kosaka, Nobuyoshi; Masuda, Norikazu
Breast cancer statistics for Japan in 2022: annual report of the national clinical database-breast cancer registry-clinical implications including chemosensitivity of breast cancer with low estrogen receptor expression
BREAST CANCER
IF2.9
2025-02-060
OAAI
Nagahashi, Masayuki; Kumamaru, Hiraku; Kinukawa, Naoko; Iwamoto, Takayuki; Kawashima, Masahiro; Kinoshita, Takayuki; Konishi, Takaaki; Sagara, Yasuaki; Sasada, Shinsuke; Saji, Shigehira; Sanuki, Naoko; Tanakura, Kenta; Niikura, Naoki; Miyashita, Minoru; Yoshida, Masayuki; Ishida, Takanori; Taira, Naruto
Real-world effectiveness of palbociclib(PAL) plus endocrine therapy (ET) in HER2-low breast cancer in the first-line(1L) or second-line (2L) setting:A Japanese multicenter observational study(PBRIDGE study)

帕博西利尼（PAL）联合内分泌治疗（ET）在HER2低表达乳腺癌的一线（1L）或二线（2L）治疗中的真实世界有效性：一项日本多中心观察性研究（PBRIDGE研究）

BREAST
IF7.9
2025-02-010
OAAI
Hattori, M.; Nagai, S. E.; Yoshinami, T.; Masuda, H.; Okamura, T.; Watanabe, K.; Nakayama, T.; Tsuneizumi, M.; Takabatake, D.; Harao, M.; Yoshino, H.; Mori, N.; Yasojima, H.; Oshiro, C.; Iwase, M.; Yamaguchi, M.; Sangai, T.; Sasada, S.; Suehiro, M.; Masuda, N.
Overall survival of palbociclib (PAL) plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive (HR plus )/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) in the 1st line (1L) or 2nd line (2L) setting: A multicenter observational study

日本激素受体阳性(HR+)/人表皮生长因子受体2阴性(HER2-)晚期乳腺癌(ABC)患者中，帕博西利(PAL)联合内分泌疗法(ET)在一线(1L)或二线(2L)治疗设置下的总生存期：一项多中心观察性研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Nakayama, T.; Nagai, S. E.; Hattori, M.; Yoshinami, T.; Masuda, H.; Okamura, T.; Watanabe, K-I.; Tsuneizumi, M.; Takabatake, D.; Harao, M.; Yasojima, H.; Oshiro, C.; Iwase, M.; Yamaguchi, M.; Sangai, T.; Sasada, S.; Ishida, T.; Futamura, M.; Kosaka, N.; Masuda, N.

研究方向

暂未获取到该数据
T
Takayuki Kadoya
H 指数:25论文数:178被引数:2,563
A
Akiko Emi
H 指数:14论文数:91被引数:509
A
Akiko Ogiya
H 指数:15论文数:85被引数:645
H
Hirohito Seki
H 指数:10论文数:94被引数:255
N
Naomi Nagura
H 指数:8论文数:56被引数:140
A
Ayaka Shimo
H 指数:8论文数:29被引数:164
M
Morihito Okada
H 指数:33论文数:297被引数:3,692
H
Hiroko Nogi
H 指数:13论文数:84被引数:590
M
Makoto Ishitobi
H 指数:31论文数:174被引数:3,693
K
Kazutaka Narui
H 指数:16论文数:184被引数:1,237